Targeting triple negative human breast cancer with omega-3 docosahexaenoic acid (DHA) and tocotrienol
Triple negative breast cancers (TNBCs) account for ~15-20% of human breast cancers in Western countries. TNBCs are associated with poor prognosis and a low five year survival rate due, in part, to high rates of tumor recurrence, multi-drug resistance, metastasis, and therapeutic toxicity. Tumor init...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en_US |
| Published: |
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/21529 |